Home > > > > > Report Detail

Global (United States, European Union and China) Hypertension Drugs Market Research Report 2019-2025

Publisher Name :
Date: 13-Aug-2019
No. of pages: 116
Inquire Before Buying

The standard definition of high blood pressure is determined by the Joint National Committee (JNC) on Detection, Evaluation, and Diagnosis of High Blood Pressure. A person is considered to have high blood pressure after three to six elevated blood pressure measurements over several months. These definitions apply to adults who are healthy and not using medication for high blood pressure. If the two pressures fall in different categories, the higher one is used to determine the severity of hypertension.

With an increase in the population of older people, the market for hypertension drugs has a positive outlook over the forecast period. The prevalence of hypertension is high among the older population with close to 70% of the patients with high BP above the age of 60. Currently, close to 11% of the global population is aged 60 years or over and is estimated to reach nearly 22% by 2050. Since the risk of developing pulmonary hypertension increases with age, a growing older population will aid in the growth prospects of the hypertension drugs market in the coming years. 

In 2015, the Americas was the largest market for hypertension drugs as it accounted for more than 44% of the market share. The US is the major revenue contributor in the region. The market share is declining due to the patent expiries of drugs such as Micardis, Avapro, and Diovan. However, comorbid conditions among the older population like congenital heart disease and increasing focus on combination therapies will prevent the decline in the market. Moreover, the launch of new disease-modifying therapies is expected to bolster the growth prospects of the market during the forecast period.

In 2019, the market size of Hypertension Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Hypertension Drugs.

This report studies the global market size of Hypertension Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Hypertension Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Novartis

- Daiichi Sankyo

- Actelion Pharmaceuticals

- Boehringer Ingelheim

- Pfizer

- ...

Market Segment by Product Type

- Calcium Channel Blockers

- Diuretics

- Beta Blockers Vasodilators

- Angiotensin Converting Enzyme Inhibitors

- Alpha Blockers

- Angiotensin Receptor Blockers

- Renin Inhibitors

Market Segment by Application

- Hospitals

- Clinics

- Others

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Hypertension Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Hypertension Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Hypertension Drugs are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Hypertension Drugs Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Hypertension Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Calcium Channel Blockers
1.3.3 Diuretics
1.3.4 Beta Blockers Vasodilators
1.3.5 Angiotensin Converting Enzyme Inhibitors
1.3.6 Alpha Blockers
1.3.7 Angiotensin Receptor Blockers
1.3.8 Renin Inhibitors
1.4 Market Segment by Application
1.4.1 Global Hypertension Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hypertension Drugs Market Size
2.1.1 Global Hypertension Drugs Revenue 2014-2025
2.1.2 Global Hypertension Drugs Sales 2014-2025
2.2 Hypertension Drugs Growth Rate by Regions
2.2.1 Global Hypertension Drugs Sales by Regions 2014-2019
2.2.2 Global Hypertension Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Hypertension Drugs Sales by Manufacturers
3.1.1 Hypertension Drugs Sales by Manufacturers 2014-2019
3.1.2 Hypertension Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Hypertension Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Hypertension Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Hypertension Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Hypertension Drugs Price by Manufacturers
3.4 Key Manufacturers Hypertension Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Hypertension Drugs Market
3.6 Key Manufacturers Hypertension Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Calcium Channel Blockers Sales and Revenue (2014-2019)
4.1.2 Diuretics Sales and Revenue (2014-2019)
4.1.3 Beta Blockers Vasodilators Sales and Revenue (2014-2019)
4.1.4 Angiotensin Converting Enzyme Inhibitors Sales and Revenue (2014-2019)
4.1.5 Alpha Blockers Sales and Revenue (2014-2019)
4.1.6 Angiotensin Receptor Blockers Sales and Revenue (2014-2019)
4.1.7 Renin Inhibitors Sales and Revenue (2014-2019)
4.2 Global Hypertension Drugs Sales Market Share by Type
4.3 Global Hypertension Drugs Revenue Market Share by Type
4.4 Hypertension Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Hypertension Drugs Sales by Application
6 United States
6.1 United States Hypertension Drugs Breakdown Data by Company
6.2 United States Hypertension Drugs Breakdown Data by Type
6.3 United States Hypertension Drugs Breakdown Data by Application
7 European Union
7.1 European Union Hypertension Drugs Breakdown Data by Company
7.2 European Union Hypertension Drugs Breakdown Data by Type
7.3 European Union Hypertension Drugs Breakdown Data by Application
8 China
8.1 China Hypertension Drugs Breakdown Data by Company
8.2 China Hypertension Drugs Breakdown Data by Type
8.3 China Hypertension Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Hypertension Drugs Breakdown Data by Company
9.2 Rest of World Hypertension Drugs Breakdown Data by Type
9.3 Rest of World Hypertension Drugs Breakdown Data by Application
9.4 Rest of World Hypertension Drugs Breakdown Data by Countries
9.4.1 Rest of World Hypertension Drugs Sales by Countries
9.4.2 Rest of World Hypertension Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Hypertension Drugs
10.1.4 Hypertension Drugs Product Introduction
10.1.5 Novartis Recent Development
10.2 Daiichi Sankyo
10.2.1 Daiichi Sankyo Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Hypertension Drugs
10.2.4 Hypertension Drugs Product Introduction
10.2.5 Daiichi Sankyo Recent Development
10.3 Actelion Pharmaceuticals
10.3.1 Actelion Pharmaceuticals Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Hypertension Drugs
10.3.4 Hypertension Drugs Product Introduction
10.3.5 Actelion Pharmaceuticals Recent Development
10.4 Boehringer Ingelheim
10.4.1 Boehringer Ingelheim Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Hypertension Drugs
10.4.4 Hypertension Drugs Product Introduction
10.4.5 Boehringer Ingelheim Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Hypertension Drugs
10.5.4 Hypertension Drugs Product Introduction
10.5.5 Pfizer Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Hypertension Drugs Sales Channels
11.2.2 Hypertension Drugs Distributors
11.3 Hypertension Drugs Customers
12 Market Forecast
12.1 Global Hypertension Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Hypertension Drugs Sales Forecast by Type
12.3 Global Hypertension Drugs Sales Forecast by Application
12.4 Hypertension Drugs Forecast by Regions
12.4.1 Global Hypertension Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Hypertension Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Hypertension Drugs Product Picture
Table Hypertension Drugs Key Market Segments
Table Major Manufacturers Hypertension Drugs Covered in This Report
Table Global Hypertension Drugs Market Size Growth Rate by Type 2019-2025 (K MT) & (Million US$)
Figure Global Hypertension Drugs Sales Market Shar by Type 2014-2025
Figure Calcium Channel Blockers Figures
Table Major Manufacturers of Calcium Channel Blockers
Figure Diuretics Figures
Table Major Manufacturers of Diuretics
Figure Beta Blockers Vasodilators Figures
Table Major Manufacturers of Beta Blockers Vasodilators
Figure Angiotensin Converting Enzyme Inhibitors Figures
Table Major Manufacturers of Angiotensin Converting Enzyme Inhibitors
Figure Alpha Blockers Figures
Table Major Manufacturers of Alpha Blockers
Figure Angiotensin Receptor Blockers Figures
Table Major Manufacturers of Angiotensin Receptor Blockers
Figure Renin Inhibitors Figures
Table Major Manufacturers of Renin Inhibitors
Table Global Hypertension Drugs Market Share by Application 2019-2025 (K MT)
Figure Hospitals Use Case
Figure Clinics Use Case
Figure Others Use Case
Figure Hypertension Drugs Report Years Considered
Figure Global Hypertension Drugs Market Size 2014-2025 (Million US$)
Figure Global Hypertension Drugs Sales 2014-2019 (K MT)
Table Global Hypertension Drugs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Hypertension Drugs Sales by Regions 2014-2019 (K MT)
Table Global Hypertension Drugs Sales Market Share by Regions 2014-2019
Figure Global Hypertension Drugs Sales Market Share by Regions 2014-2019
Figure Global Hypertension Drugs Sales Market Share by Regions in 2019
Table Global Hypertension Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Hypertension Drugs Revenue Market Share by Regions 2014-2019
Figure Global Hypertension Drugs Revenue Market Share by Regions 2014-2019
Figure Global Hypertension Drugs Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Hypertension Drugs Sales by Manufacturers (2014-2019) (K MT)
Table Global Hypertension Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Hypertension Drugs Sales Share by Manufacturers in 2019
Table Hypertension Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Hypertension Drugs Revenue Share by Manufacturers (2014-2019)
Figure Hypertension Drugs Value Share by Manufacturers in 2019
Table Global Hypertension Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Hypertension Drugs Price (2014-2019) (USD/MT)
Table Key Manufacturers Hypertension Drugs Plants/Factories Distribution
Table Key Manufacturers Hypertension Drugs Area Served
Table Date of Key Manufacturers Enter into Hypertension Drugs Market
Table Key Manufacturers Hypertension Drugs Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Calcium Channel Blockers Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Diuretics Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Beta Blockers Vasodilators Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Angiotensin Converting Enzyme Inhibitors Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Alpha Blockers Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Angiotensin Receptor Blockers Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Renin Inhibitors Sales and Revenue (2014-2019) (K MT) & (Million US$)
Table Global Hypertension Drugs Sales by Type (2014-2019) (K MT)
Table Global Hypertension Drugs Sales Share by Type (2014-2019)
Figure Global Hypertension Drugs Sales Market Share by Type (2014-2019)
Figure Global Hypertension Drugs Sales Market Share by Type in 2018
Table Global Hypertension Drugs Revenue by Type (2014-2019) (Million US$)
Table Global Hypertension Drugs Revenue Share by Type (2014-2019)
Figure Global Hypertension Drugs Revenue Market Share by Type (2014-2019)
Figure Global Hypertension Drugs Revenue Market Share by Type in 2018
Table Hypertension Drugs Price by Type 2014-2019 (USD/MT)
Table Global Hypertension Drugs Sales by Application (2014-2019) (K MT)
Table Global Hypertension Drugs Sales Share by Application (2014-2019)
Figure Global Sales Hypertension Drugs Market Share by Application (2014-2019)
Figure Global Sales Hypertension Drugs Market Share by Application (2014-2019)
Figure United States Hypertension Drugs Sales Growth Rate 2014-2019 (K MT)
Figure United States Hypertension Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table United States Hypertension Drugs Sales by Company (2014-2019) (K MT)
Table United States Hypertension Drugs Sales Market Share by Company (2014-2019)
Figure United States Hypertension Drugs Sales Market Share by Company in 2019
Table United States Hypertension Drugs Sales by Type (2014-2019) (K MT)
Table United States Hypertension Drugs Sales Market Share by Type (2014-2019)
Figure United States Hypertension Drugs Market Share by Type in 2019
Table United States Hypertension Drugs Sales by Application (2014-2019) (K MT)
Table United States Hypertension Drugs Sales Market Share by Application (2014-2019)
Figure United States Hypertension Drugs Market Share by Application in 2019
Figure European Union Hypertension Drugs Sales Growth Rate 2014-2019 (K MT)
Figure European Union Hypertension Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Hypertension Drugs Sales by Company (2014-2019) (K MT)
Table European Union Hypertension Drugs Sales Market Share by Company (2014-2019)
Figure European Union Hypertension Drugs Sales Market Share by Company in 2019
Table European Union Hypertension Drugs Sales by Type (2014-2019) (K MT)
Table European Union Hypertension Drugs Sales Market Share by Type (2014-2019)
Figure 2018 European Union Hypertension Drugs Market Share by Type
Table European Union Hypertension Drugs Sales by Application (2014-2019) (K MT)
Table European Union Hypertension Drugs Sales Market Share by Application (2014-2019)
Figure 2018 European Union Hypertension Drugs Market Share by Application
Figure China Hypertension Drugs Sales Growth Rate 2014-2019 (K MT)
Figure China Hypertension Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table China Hypertension Drugs Sales by Company (2014-2019) (K MT)
Table China Hypertension Drugs Sales Market Share by Company (2014-2019)
Figure China Hypertension Drugs Sales Market Share by Company in 2019
Table China Hypertension Drugs Sales by Type (2014-2019) (K MT)
Table China Hypertension Drugs Sales Market Share by Type (2014-2019)
Figure China Hypertension Drugs Market Share by Type in 2019
Table China Hypertension Drugs Sales by Application (2014-2019) (K MT)
Table China Hypertension Drugs Sales Market Share by Application (2014-2019)
Figure China Hypertension Drugs Market Share by Application in 2019
Figure Rest of World Hypertension Drugs Sales Growth Rate 2014-2019 (K MT)
Figure Rest of World Hypertension Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Hypertension Drugs Sales by Company (2014-2019) (K MT)
Table Rest of World Hypertension Drugs Sales Market Share by Company (2014-2019)
Figure Rest of World Hypertension Drugs Sales Market Share by Company in 2019
Table Rest of World Hypertension Drugs Sales by Type (2014-2019) (K MT)
Table Rest of World Hypertension Drugs Sales Market Share by Type (2014-2019)
Figure Rest of World Hypertension Drugs Market Share by Type in 2019
Table Rest of World Hypertension Drugs Sales by Application (2014-2019) (K MT)
Table Rest of World Hypertension Drugs Sales Market Share by Application (2014-2019)
Figure Rest of World Hypertension Drugs Market Share by Application in 2019
Table Rest of World Hypertension Drugs Sales by Countries (2014-2019) (K MT)
Table Rest of World Hypertension Drugs Sales Market Share by Countries (2014-2019)
Figure Rest of World Hypertension Drugs Sales Market Share by Countries in 2019
Table Rest of World Hypertension Drugs Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Hypertension Drugs Revenue Market Share by Countries (2014-2019)
Figure Rest of World Hypertension Drugs Revenue Market Share by Countries in 2019
Figure Japan Hypertension Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Hypertension Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Korea Hypertension Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Hypertension Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure India Hypertension Drugs Sales Growth Rate (2014-2019) (K MT)
Figure India Hypertension Drugs Revenue Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Hypertension Drugs Sales Growth Rate (2014-2019) (K MT)
Figure Southeast Asia Hypertension Drugs Revenue Growth Rate (2014-2019) (K MT)
Table Novartis Company Details
Table Novartis Description and Business Overview
Table Novartis Hypertension Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Hypertension Drugs Sales Growth Rate (2014-2019)
Table Novartis Hypertension Drugs Sales Market Share in Global Market
Table Novartis Recent Development
Table Daiichi Sankyo Company Details
Table Daiichi Sankyo Description and Business Overview
Table Daiichi Sankyo Hypertension Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Daiichi Sankyo Hypertension Drugs Sales Growth Rate (2014-2019)
Table Daiichi Sankyo Hypertension Drugs Sales Market Share in Global Market
Table Daiichi Sankyo Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Description and Business Overview
Table Actelion Pharmaceuticals Hypertension Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Actelion Pharmaceuticals Hypertension Drugs Sales Growth Rate (2014-2019)
Table Actelion Pharmaceuticals Hypertension Drugs Sales Market Share in Global Market
Table Actelion Pharmaceuticals Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Description and Business Overview
Table Boehringer Ingelheim Hypertension Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Boehringer Ingelheim Hypertension Drugs Sales Growth Rate (2014-2019)
Table Boehringer Ingelheim Hypertension Drugs Sales Market Share in Global Market
Table Boehringer Ingelheim Recent Development
Table Pfizer Company Details
Table Pfizer Description and Business Overview
Table Pfizer Hypertension Drugs Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2014-2019)
Table Pfizer Hypertension Drugs Sales Growth Rate (2014-2019)
Table Pfizer Hypertension Drugs Sales Market Share in Global Market
Table Pfizer Recent Development
Figure Hypertension Drugs Value Chain
Table Hypertension Drugs Distributors List
Table Hypertension Drugs Customers List
Table Global Hypertension Drugs Sales Forecast 2019-2025 (K MT) & (Million US$)
Figure Global Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure Global Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Table Global Hypertension Drugs Sales Forecast by Type 2019-2025 (K MT)
Figure Global Hypertension Drugs Sales Forecast by Type 2019-2025 (K MT)
Figure Global Hypertension Drugs Sales Market Share Forecast by Type 2019-2025
Table Global Hypertension Drugs Sales Forecast by Application 2019-2025 (K MT)
Figure Global Hypertension Drugs Sales Forecast by Application 2019-2025 (K MT)
Figure Global Hypertension Drugs Sales Market Share Forecast by Application 2019-2025
Table Global Hypertension Drugs Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Hypertension Drugs Sales Forecast by Regions 2019-2025 (K MT)
Figure Global Hypertension Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Hypertension Drugs Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Hypertension Drugs Revenue Forecast by Regions 2019-2025 (K MT)
Figure Global Hypertension Drugs Revenue Market Share Forecast by Regions 2019-2025
Figure United States Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure United States Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Figure European Union Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure European Union Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Figure China Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure China Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Japan Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure Japan Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Korea Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure Korea Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Figure India Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure India Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Hypertension Drugs Sales Forecast 2019-2025 (K MT)
Figure Southeast Asia Hypertension Drugs Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103
    Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......
  • Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102
    Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......
  • Global Amlodipine Besylate Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115
    The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......
  • Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112
    The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......
  • Captopril API - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100
    The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......
  • Telmisartan - Global Market Insights and Sales Trends 2024
    Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107
    The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......
  • Global Ambrisentan Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Ambrisentan Market Research Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132
    Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......
  • Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028
    Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs